Keyszer, G <br/><br/>
Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity.  [electronic resource] 

 -  Zeitschrift fur Rheumatologie  Dec 1998 
 - 392-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0340-1855 
<br/><br/><label>Standard No.: </label>10.1007/s003930050131  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Arthritis, Rheumatoid--diagnosis<br/>Biomarkers--blood<br/>Cathepsin B--antagonists & inhibitors<br/>Cathepsin H<br/>Cathepsin L<br/>Cathepsins--antagonists & inhibitors<br/>Collagenases--blood<br/>Cystatin A<br/>Cystatin B<br/>Cystatin C<br/>Cystatins--blood<br/>Cysteine Endopeptidases--blood<br/>Disease Progression<br/>Endopeptidases<br/>Female<br/>Humans<br/>Male<br/>Matrix Metalloproteinase 1<br/>Matrix Metalloproteinase 3--blood<br/>Matrix Metalloproteinase Inhibitors<br/>Middle Aged<br/>Predictive Value of Tests<br/>Reference Values<br/>Tissue Inhibitor of Metalloproteinase-1--blood